{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:59:02Z","timestamp":1785117542503,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institutes for Medical Research Development","award":["979157"],"award-info":[{"award-number":["979157"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03200-7","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:54:51Z","timestamp":1778860491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytomegalovirus infection drives a distinct mucosal and systemic cytokine signature in ulcerative colitis"],"prefix":"10.1186","volume":"23","author":[{"given":"Nasim","family":"Izadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Shirmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser Ebrahimi","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Bannazadeh","family":"Baghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahin Ahangar","family":"Oskouee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Sadeghipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Naghili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aghazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahdat","family":"Poortahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"10080","key":"3200_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370.","journal-title":"Lancet"},{"issue":"9853","key":"3200_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606\u201319.","journal-title":"Lancet"},{"issue":"10114","key":"3200_CR3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng SC, Shi HY, Hamidi N. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review. Lancet. 2018;390(10114):2769\u201378.","journal-title":"Lancet"},{"issue":"4","key":"3200_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7351","key":"3200_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307\u201317.","journal-title":"Nature"},{"issue":"6","key":"3200_CR6","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3748\/wjg.v22.i6.2030","volume":"22","author":"X Roblin","year":"2016","unstructured":"Roblin X, Pillet S, Oussalah A. Cytomegalovirus and ulcerative colitis: place of antiviral therapy. World J Gastroenterol. 2016;22(6):2030\u201345.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3200_CR7","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/ibd.21275","volume":"16","author":"G Lawlor","year":"2010","unstructured":"Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16(9):1620\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"3200_CR8","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","volume":"101","author":"A Kandiel","year":"2006","unstructured":"Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101(12):2857\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3200_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in IBD. J Crohns Colitis. 2014;8(6):443\u201368.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3200_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3200_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3200_CR12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2468-1253(18)30265-6","volume":"3","author":"R Atreya","year":"2018","unstructured":"Atreya R, Neurath MF. Mechanisms of molecular resistance and response to biological therapy in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2018;3(11):790\u2013802.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"3200_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamapediatrics.2017.2571","volume":"171","author":"DS Shouval","year":"2017","unstructured":"Shouval DS, Rufo PA. The role of environmental factors in the pathogenesis of inflammatory bowel diseases. JAMA Pediatr. 2017;171(10):999\u20131005.","journal-title":"JAMA Pediatr"},{"key":"3200_CR14","first-page":"728097","volume":"2012","author":"S Pillet","year":"2012","unstructured":"Pillet S, Pozzetto B, Roblin X. Cytomegalovirus infection and inflammatory bowel diseases. Clin Dev Immunol. 2012;2012:728097.","journal-title":"Clin Dev Immunol"},{"key":"3200_CR15","first-page":"1098","volume":"59","author":"YS Kim","year":"2012","unstructured":"Kim YS, Kim YH, Kim JS. Cytomegalovirus infection in patients with new-onset ulcerative colitis: a prospective study. Hepatogastroenterology. 2012;59:1098\u2013101.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"3200_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/cid\/ciw370","volume":"63","author":"JK Preiksaitis","year":"2016","unstructured":"Preiksaitis JK, Hayden RT, Tong Y. Impact of the first WHO International Standard for human cytomegalovirus DNA on assay harmonization. Clin Infect Dis. 2016;63(5):583\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3200_CR17","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3748\/wjg.v21.i6.1915","volume":"21","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R, Racca F, Paolucci S. Human cytomegalovirus and Epstein\u2013Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol. 2015;21(6):1915\u201326.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"3200_CR18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1038\/ajg.2011.202","volume":"106","author":"X Roblin","year":"2011","unstructured":"Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011;106(11):2001\u20138.","journal-title":"Am J Gastroenterol"},{"key":"3200_CR19","doi-asserted-by":"crossref","unstructured":"Maresca R, Varca S, Di Vincenzo F, Ainora ME, Mignini I, Papa A et al. Cytomegalovirus infection: an underrated target in inflammatory bowel disease treatment. J Clin Med. 2023;13(1):130.","DOI":"10.3390\/jcm13010130"},{"issue":"4","key":"3200_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"2","key":"3200_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41577-019-0225-5","volume":"20","author":"R Berry","year":"2020","unstructured":"Berry R, Watson GM, Jonjic S, Degli-Esposti MA, Rossjohn J. Modulation of innate and adaptive immunity by cytomegaloviruses. Nat Rev Immunol. 2020;20(2):113\u201327.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3200_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3200_CR23","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/JVI.78.9.4498-4507.2004","volume":"78","author":"IB DeMeritt","year":"2004","unstructured":"DeMeritt IB, Milford LE, Yurochko AD. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol. 2004;78(9):4498\u2013507.","journal-title":"J Virol"},{"issue":"16","key":"3200_CR24","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1128\/JVI.01234-15","volume":"89","author":"S Rattay","year":"2015","unstructured":"Rattay S, Trilling M, Megger DA, Sitek B, Meyer HE, Hengel H, et al. The Canonical Immediate Early 3 Gene Product pIE611 of Mouse Cytomegalovirus Is Dispensable for Viral Replication but Mediates Transcriptional and Posttranscriptional Regulation of Viral Gene Products. J Virol. 2015;89(16):8590\u20138.","journal-title":"J Virol"},{"issue":"1","key":"3200_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12985-025-02725-7","volume":"22","author":"MX Chen","year":"2025","unstructured":"Chen MX, Chen Y, Fu R, Wang JY, Liu SY, Shen TB. Cytomegalovirus infection initiates inflammatory bowel disease by activating a positive MyD88\/NF-kappaB feedback loop in allogeneic skin transplantation mice. Virol J. 2025;22(1):101.","journal-title":"Virol J"},{"issue":"1","key":"3200_CR26","first-page":"1","volume":"18","author":"P Eder","year":"2023","unstructured":"Eder P, Lodyga M, Gawron-Kiszka M, Dobrowolska A, Gonciarz M, Hartleb M, et al. Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Prz Gastroenterol. 2023;18(1):1\u201342.","journal-title":"Prz Gastroenterol"},{"issue":"7","key":"3200_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.crohns.2013.12.014","volume":"8","author":"JW Kim","year":"2014","unstructured":"Kim JW, Boo SJ, Ye BD, Kim CL, Yang SK, Kim J, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014;8(7):693\u2013701.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"3200_CR28","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3748\/wjg.v22.i6.2030","volume":"22","author":"S Pillet","year":"2016","unstructured":"Pillet S, Pozzetto B, Roblin X. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy. World J Gastroenterol. 2016;22(6):2030.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"3200_CR29","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/2211-5463.12334","volume":"7","author":"S Wang","year":"2017","unstructured":"Wang S, Dou Y, Yang H, Ni A, Zhang R, Qian J. Alteration of glucocorticoid receptors and exacerbation of inflammation during lytic cytomegalovirus infection in THP-1 cells. FEBS Open Bio. 2017;7(12):1924\u201331.","journal-title":"FEBS Open Bio"},{"issue":"11","key":"3200_CR30","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.4049\/jimmunol.2300742","volume":"213","author":"R Dhital","year":"2024","unstructured":"Dhital R, Flint K, Kaptsan I, Hegde S, Daloul R, Shimamura M. Virus-specific Th17 Cells Are Induced by Human Cytomegalovirus after Renal Transplantation. J Immunol. 2024;213(11):1703\u201312.","journal-title":"J Immunol"},{"issue":"6","key":"3200_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/ajt.12725","volume":"14","author":"S Roy","year":"2014","unstructured":"Roy S, Arav-Boger R. New cell-signaling pathways for controlling cytomegalovirus replication. Am J Transpl. 2014;14(6):1249\u201358.","journal-title":"Am J Transpl"},{"issue":"5","key":"3200_CR32","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s10620-010-1162-0","volume":"55","author":"H Nakase","year":"2010","unstructured":"Nakase H, Yoshino T, Honzawa Y, Chiba T. Low prevalence of CMV infection in patients with Crohn\u2019s disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci. 2010;55(5):1498\u20139.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3200_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/biomedicines13020338","volume":"13","author":"I Anindya","year":"2025","unstructured":"Anindya I, Sekartini R, Ariyanto IA, Wiguna T, Sari NP, Rahayu YS, et al. Cytomegalovirus-Reactive IgG Correlates with Increased IL-6 and IL-1\u03b2 Levels, Affecting Eating Behaviours and Tactile Sensitivity in Children with Autism. Biomedicines. 2025;13(2):338.","journal-title":"Biomedicines"},{"issue":"6","key":"3200_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00284-023-03305-0","volume":"80","author":"T Dehghani","year":"2023","unstructured":"Dehghani T, Gholizadeh O, Daneshvar M, Nemati MM, Akbarzadeh S, Amini P, et al. Association between inflammatory bowel disease and viral infections. Curr Microbiol. 2023;80(6):195.","journal-title":"Curr Microbiol"},{"issue":"7","key":"3200_CR35","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/microorganisms8071078","volume":"8","author":"A Jentzer","year":"2020","unstructured":"Jentzer A, Veyrard P, Roblin X, Saint-Sardos P, Rochereau N, Paul S, et al. Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC). Microorganisms. 2020;8(7):1078.","journal-title":"Microorganisms"},{"issue":"12","key":"3200_CR36","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/pathogens11121547","volume":"11","author":"M Paroli","year":"2022","unstructured":"Paroli M, Caccavale R, Fiorillo MT, Spadea L, Gumina S, Candela V, et al. The double game played by Th17 cells in infection: host defense and immunopathology. Pathogens. 2022;11(12):1547.","journal-title":"Pathogens"},{"issue":"1","key":"3200_CR37","first-page":"651503","volume":"2014","author":"JF Zambrano-Zaragoza","year":"2014","unstructured":"Zambrano-Zaragoza JF, Romo-Mart\u00ednez EJ, Dur\u00e1n-Avelar MDJ, Garc\u00eda-Magallanes N. Vibanco-P\u00e9rez N. Th17 cells in autoimmune and infectious diseases. Int J Inflamm. 2014;2014(1):651503.","journal-title":"Int J Inflamm"},{"issue":"10","key":"3200_CR38","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1111\/ajt.17116","volume":"22","author":"R Dhital","year":"2022","unstructured":"Dhital R, Anand S, Graber B, Zeng Q, Velazquez VM, Boddeda SR, et al. Murine cytomegalovirus promotes renal allograft inflammation via Th1\/17 cells and IL-17A. Am J Transplant. 2022;22(10):2306\u201322.","journal-title":"Am J Transplant"},{"issue":"5","key":"3200_CR39","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1097\/TP.0000000000003138","volume":"104","author":"TA Heald-Sargent","year":"2020","unstructured":"Heald-Sargent TA, Forte E, Liu X, Thorp EB, Abecassis MM, Zhang ZJ, et al. New insights into the molecular mechanisms and immune control of cytomegalovirus reactivation. Transplantation. 2020;104(5):e118\u201324.","journal-title":"Transplantation"},{"issue":"11","key":"3200_CR40","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/diagnostics11111952","volume":"11","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang G, Kong D, Li G, Wang H, Qin H, et al. Risk factors of cytomegalovirus reactivation in ulcerative colitis patients: a meta-analysis. Diagnostics. 2021;11(11):1952.","journal-title":"Diagnostics"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03200-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:07:07Z","timestamp":1785114427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03200-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3200"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03200-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This investigation was carried out in accordance with the principles of the Helsinki Declaration. Ethical approval was granted by the Research Ethics Committees of National Institute for Medical Research Development (IR.NIMAD.REC.1398.236). All participants provided written informed consent prior to their enrollment in the study. The principal investigator, Vahdat Poortahmasebi, ensured the ethical handling and confidentiality of patient data. Written informed consent was obtained from all individual participants prior to their enrollment in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"180"}}